UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053580
Receipt number R000061146
Scientific Title Effects of sunburn on exercise performance
Date of disclosure of the study information 2024/02/09
Last modified on 2024/02/09 15:35:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of sunburn on exercise performance

Acronym

Sunburn and performance

Scientific Title

Effects of sunburn on exercise performance

Scientific Title:Acronym

Sunburn and performance

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the effects of sunburn on immune function, oxidative stress, fatigue, and exercise performance.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Exercise performance (grip strength, vertical jump, reaction time, agility, anaerobic capacity) at 6 hours after sunburn

Key secondary outcomes

Salivary biomarkers, urinary biomarkers, autonomic nerve activity, mood states, and fatigue


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Sunburn equivalent to minimal erythema dose (MED)

Interventions/Control_2

Rest for the same amount of time as MED

Interventions/Control_3

Sunburn equivalent to twofold MED

Interventions/Control_4

Rest for the same amount of time as twofold MED

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Persons who are able to obtain free and voluntary consent to participate in research in writing from the individual
Men and women between the ages of 18 and 40 at the time of consent
Persons who are willing to comply with the study protocol and agree to participate in the study

Key exclusion criteria

Women who are pregnant or may become pregnant
Persons who are considered to have difficulty in daily living due to surgical injuries or medical conditions
Subjects who have difficulty in exposing themselves to ultraviolet rays of the sun due to skin diseases, photosensitivity, etc.
Persons who are deemed inappropriate as subjects for this study by the principal investigator and the person in charge of the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Nobuhiko
Middle name
Last name Eda

Organization

Dokkyo Medical University

Division name

Premedical Sciences, Department of Fundamental Education

Zip code

321-0293

Address

880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, Japan

TEL

0282-87-2119

Email

n-eda@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Nobuhiko
Middle name
Last name Eda

Organization

Dokkyo Medical University

Division name

Premedical Sciences, Department of Fundamental Education

Zip code

321-0293

Address

880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, Japan

TEL

0282-87-2119

Homepage URL


Email

n-eda@dokkyomed.ac.jp


Sponsor or person

Institute

Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Bioethics Committee, Dokkyo Medical University

Address

880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, Japan

Tel

0282-87-2474

Email

kenkyu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 01 Month 04 Day

Date of IRB

2024 Year 02 Month 05 Day

Anticipated trial start date

2024 Year 02 Month 14 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 09 Day

Last modified on

2024 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061146


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name